Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Nat Med. 2023 Oct;29(10):2615-2624. doi: 10.1038/s41591-023-02561-8. Epub 2023 Sep 28.
Nat Med. 2023.
PMID: 37770652
Free PMC article.
Clinical Trial.
Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [18F]NaF PET/CT study.
Botman E, Raijmakers PGHM, Yaqub M, Teunissen B, Netelenbos C, Lubbers W, Schwarte LA, Micha D, Bravenboer N, Schoenmaker T, de Vries TJ, Pals G, Smit JM, Koolwijk P, Trotter DG, Lammertsma AA, Eekhoff EMW.
Botman E, et al. Among authors: trotter dg.
Bone. 2019 Jul;124:1-6. doi: 10.1016/j.bone.2019.03.009. Epub 2019 Mar 8.
Bone. 2019.
PMID: 30858149
Item in Clipboard
Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model.
Kularatne SA, Bélanger MJ, Meng X, Connolly BM, Vanko A, Suresch DL, Guenther I, Wang S, Low PS, McQuade P, Trotter DG.
Kularatne SA, et al. Among authors: trotter dg.
Mol Pharm. 2013 Aug 5;10(8):3103-11. doi: 10.1021/mp4001684. Epub 2013 Jul 24.
Mol Pharm. 2013.
PMID: 23819524
Item in Clipboard
Cite
Cite